Monaco Asset Management SAM

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 1803593 Monaco, O9

Position in VNDA

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$1,354,270

-$313,016 QoQ

Shares Held

221,286

-8.3% QoQ

Ownership

0.366%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

#35

of 169 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Monaco Asset Management SAM holds $49,930,003 across 9 Biotechnology names. VNDA ranks #7 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRVI	Maravai Lifesciences Holdings, Inc.	2,231,026	$13,921,602
2	BMRN	Biomarin Pharmaceutical Inc	184,937	$10,582,095
3	RCKT	Rocket Pharmaceuticals, Inc.	2,480,468	$8,483,200
4	NKTX	Nkarta, Inc.	2,373,400	$6,716,722
5	NVAX	Novavax Inc	577,464	$5,439,710
6	PLRX	Pliant Therapeutics, Inc.	1,938,747	$2,210,171
7	VNDA	Vanda Pharmaceuticals Inc. This page	221,286	$1,354,270
8	LKFT	Lakefront Biotherapeutics NV	25,600	$767,488

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,354,270	221,286	-8.3%	Shares	Sole	2026-08-07
2026-03-31	$1,667,286	241,286	+22.9%	Shares	Sole	2026-05-11
2025-12-31	$1,731,242	196,286	-20.8%	Shares	Sole	2026-02-10
2025-09-30	$1,236,546	247,805	-18.8%	Shares	Sole	2025-11-10
2025-06-30	$1,439,600	305,000	-6.2%	Shares	Sole	2025-08-07
2025-03-31	$1,491,750	325,000	-17.1%	Shares	Sole	2025-05-08
2024-12-31	$1,878,934	392,262	+92.8%	Shares	Sole	2025-02-10
2024-09-30	$954,067	203,426	+5.4%	Shares	Sole	2024-11-07
2024-06-30	$1,090,031	192,926	+127.0%	Shares	Sole	2024-08-07
2023-12-31	$358,700	85,000	-37.0%	Shares	Sole	2024-02-07
2023-09-30	$583,200	135,000	—	Shares	Sole	2023-11-07
No filing history on record for this holder in this stock.